Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00864_DB01263_nanopub.RAxDalmgk4JMM8Z4_yTYFjVSYiL-iLMOJyOeqgOBa9TFc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00864_DB01263 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00864_DB01263 label "DDI between Tacrolimus and Posaconazole - The strong CYP3A4 inhibitor, Posaconazole, may decrease the metabolism and clearance of Tacrolimus, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Tacrolimus if Posaconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00864_DB01263]" assertion.
- drugbank_resource:DB00864_DB01263 identifier "drugbank_resource:DB00864_DB01263" assertion.
- drugbank_resource:DB00864_DB01263 title "DDI between Tacrolimus and Posaconazole - The strong CYP3A4 inhibitor, Posaconazole, may decrease the metabolism and clearance of Tacrolimus, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Tacrolimus if Posaconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00864 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00864_DB01263 assertion.
- drugbank:DB01263 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00864_DB01263 assertion.